• 1:中华预防医学会

摘要(Abstract)：

A组轮状病毒(Group A rotavirus,RV)是引起中国<5岁儿童重度胃肠炎和死亡的主要病原之一。接种RV疫苗是预防控制儿童轮状病毒胃肠炎(Rotavirus gastroenteritis,RVGE)的最有效措施。本共识通过回顾RV相关文献,结合中国RV疾病监测数据、世界卫生组织(World Health Organization,WHO)RV疫苗立场文件和专家研讨意见编写而成,旨在为中国儿童RV疫苗使用提供相关科学信息,供专业技术人员在相关工作中参考使用,为制定中国儿童RVGE免疫预防策略提供循证依据。

关键词(KeyWords)： 轮状病毒胃肠炎;轮状病毒疫苗;免疫预防;共识

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1] World Health Organization.Rotavirus vaccines WHO position paper-January 2013[J].Weekly Epidemiological Record,2013,88(5):49-64.
• [2] PARASHAR DU,NELSON ASE,KANG G.Diagnosis,management,and prevention of rotavirus gastroenteritis in children[J].British Medical Journal,2013,347:7204.
• [3] World Health Organization.Child rotavirus deaths by country 2000-2013[EB/OL].(2016-04-15) [2020-08-24].http://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/.
• [4] World Health Organization.Rotavirus vaccines in routine immunization.Pocket Guide[M].Switzerland:World Health Organization,2012.
• [5] Plotkin SA,Orenstein WA,Offit PA.Vaccines (6 edtiion)[M]//罗凤基,杨晓明,王军志,等译.疫苗第6版(上册)[M].第2版.北京:人民卫生出版社,2016:1017-1018.
• [6] World Health Organization/The United Nations Children’s Fund (UNICEF).Ending preventable child deaths from pneumonia and diarrhoea by 2025.The integrated global action plan for pneumonia and diarrhoea (GAPPD)[S].Switzerland:World Health Organization,2013.
• [7] ASMA S,NAZISH B,KWE CLAUDE YK,et al.Rotavirus:genetics,pathogenesis and vaccine advances[J].Reviews in Medical Virology,2018,28(6):e2003.
• [8] CRAWFORD SE,RAMANI S,TATE JE,et al.Rotavirus infection[J].Nat Rev Dis Primers,2017,3:17083.
• [9] LUCHS A,TIMENETSKY M.Group A rotavirus gastroenteritis:post-vaccine era,genotypes and zoonotic transmission[J].Einstein (Sao Paulo),2016,14(2):278-287.
• [10] SANTOS N,HOSHINO Y.Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine[J].Reviews in Medical Virology,2005,15(1):29-56.
• [11] ANSARI SA,SPRINGTHORPE VS,SATTAR SA.Survival and vehicular spread of human rotaviruses:possible relation to seasonality of outbreaks[J].Reviews of Infectious Diseases,1991,13(3):448-461.
• [12] DENNEHY PH.Transmission of rotavirus and other enteric pathogens in the home[J].The Pediatric Infectious Disease Journal,2000,19(10 Suppl):103-105.
• [13] DENNEHY PH.Rotavirus infection:a disease of the past?[J].Infectious Disease Clinics of North America,2015,29(4):617-635.
• [14] KNIPE DM,HOWLEY PM.Fields Virology[M].6th ed.Philadelphia:Wolters Kluwer Health/Lippincott Williams & Wilkins,2013:1347-1401.
• [15] ANGEL J,FRANCO MA,GREENBERG HB.Rotavirus immune responses and correlates of protection[J].Current Opinion in Virology,2012,2(4):419-425.
• [16] ANGEL J,FRANCO MA,GREENBERG HB.Rotavirus vaccines:recent developments and future considerations[J].Nature Reviews Microbiology,2007,5(7):529-539.
• [17] JOHANSEN K,SVENSSON L.Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA[J].Archives of Virology,1997,142(7):1491-1498.
• [18] FRANCO MA,ANGEL J,GREENBERG HB.Immunity and correlates of protection for rotavirus vaccines[J].Vaccine,2006,24(15):2718-2731.
• [19] ULRICH D,HANS-IKO H.Immune responses to rotavirus infection and vaccination and associated correlates of protection[J].The Journal of Infectious Diseases,2011,203(2):188-195.
• [20] VELáZQUEZ FR,MATSON DO,CALVA JJ,et al.Rotavirus infection in infants as protection against subsequent infections[J].The New England Journal of Medicine,1996,335(14):1022-1028.
• [21] FISCHER TK,VALENTINER-BRANTH P,STEINSLAND H,et al.Protective immunity after natural rotavirus infection:a community cohort study of newborn children in Guinea-Bissau,West Africa[J].The Journal of Infectious Diseases,2002,186(5):593-597.
• [22] BERYL PGPD,SASIREKHA RPD,INDRANI MPD,et al.Protective effect of natural rotavirus infection in an Indian birth cohort[J].The New England Journal of Medicine,2011,365(4):337-346.
• [23] WARD RL,CLARK HF,OFFIT PA.Influence of potential protective mechanisms on the development of live rotavirus vaccines[J].The Journal of Infectious Diseases,2010,202(Suppl):72-79.
• [24] CLARKE E,DESSELBERGER U.Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings[J].Mucosal Immunology,2015,8(1):1-17.
• [25] LEE RM,LESSLER J,LEE RA,et al.Incubation periods of viral gastroenteritis:a systematic review[J].BMC Infect Dis,2013,13(1):446.
• [26] SMIYAN OI,SMIIAN-HORBUNOVA KO,BYNDA TP,et al.Optimization of the treatment of rotavirus infection in children by using bacillus clausii[J].Wiadomosci Lekarskie (Warsaw,Poland:1960),2019,72(7):1320-1323.
• [27] NEWMAN RD,GRUPP-PHELAN J,SHAY DK,et al.Perinatal risk factors for infant hospitalization with viral gastroenteritis[J].Pediatrics,1999,103(1):E3.
• [28] BLUTT SE,MATSON DO,CRAWFORD SE,et al.Rotavirus antigenemia in children is associated with viremia[J].PLoS Medicine,2007,4(4):e121.
• [29] INEKO N,KOKI T,HATSUE IU,et al.Sudden death from systemic rotavirus infection and detection of nonstructural rotavirus proteins[J].Journal of Clinical Microbiology,2011,49(12):4382-4385.
• [30] RIVERO-CALLE I,GóMEZ-RIAL J,MARTINóN-TORRES F.Systemic features of rotavirus infection[J].Journal of Infection,2016,72(Suppl):98-105.
• [31] GóMEZ-RIAL J,RIVERO-CALLE I,SALAS A,et al.Rotavirus and autoimmunity[J].Journal of Infection,2020,81(2):183-189.
• [32] LUKACIK M,THOMAS RL,ARANDA JV.A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea[J].Pediatrics,2008,121(2):326-336.
• [33] MARCY SM,PARTRIDGE S.Rotavirus infection//Jong EC,Stevens DL,Netter’s Infectious Diseases[M].W.B.Saunders,2012:39-41.
• [34] ISA P,ARIAS CF,LóPEZ S.Role of sialic acids in rotavirus infection[J].Glycoconjugate Journal,2006,23(1-2):27-37.
• [35] HUANG P,XIA M,TAN M,et al.Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner[J].Journal of Virology,2012,86(9):4833-4843.
• [36] HU L,SANKARAN B,LAUCIRICA DR,et al.Glycan recognition in globally dominant human rotaviruses[J].Nature Communications,2018,9(1):2631.
• [37] GOZALBO-ROVIRA R,CIGES-TOMAS JR,VILA-VICENT S,et al.Unraveling the role of the secretor antigen in human rotavirus attachment to histo-blood group antigens[J].PLoS Pathogens,2019,15(6):1007865.
• [38] NGUYEN VT,THIBICH VH,THIHONG LN,et al.Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children[J].Journal of Clinical Microbiology,2014,52(5):1366-1374.
• [39] KHACHOU A,MOULLAC-VAIDYE BL,PELTIER C,et al.Host-range shift between emerging P[8]- 4 rotavirus and common P[8] and P[4] strains[J].The Journal of Infectious Diseases,2020,222(5):836-839.
• [40] SHARMA S,HAGBOM M,SVENSSON L,et al.The impact of human genetic polymorphisms on rotavirus susceptibility,epidemiology,and vaccine take[J].Viruses,2020,12(3):324.
• [41] CORTESE MM,PARASHAR UD.Prevention of rotavirus gastroenteritis among infants and children:recommendations of the Advisory Committee on Immunization Practices (ACIP)[J].MMWR Recommendations and Reports,2009,58(RR-2):1-25.
• [42] ALIABADI N,ANTONI S,MWENDA JM,et al.Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age,2008-16:findings from the Global Rotavirus Surveillance Network[J].The Lancet Global Health,2019,7(7):893-903.
• [43] 中国疾病预防控制中心.中国重点传染病和病媒生物监测报告(内部资料)[R].2016.
• [44] 张平,张静.我国2014-2015年其他感染性腹泻监测现状分析[J].中华流行病学杂志,2017,38(4):424-430.
• [45] PATEL MM,PITZER VE,ALONSO WJ,et al.Global seasonality of rotavirus disease[J].The Pediatric Infectious Disease Journal,2013,32(4):134-147.
• [46] TATE JE,PANOZZO CA,PAYNE DC,et al.Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine[J].Pediatrics,2009,124(2):465-471.
• [47] FANG ZY,YANG H,QI J,et al.Diversity of rotavirus strains among children with acute diarrhea in China:1998-2000 surveillance study[J].Journal of Clinical Microbiology,2002,40(5):1875-1878.
• [48] DUAN ZJ,LIU N,YANG SH,et al.Hospital-based surveillance of rotavirus diarrhea in the People's Republic of China,August 2003-July 2007[J].The Journal of Infectious Diseases,2009,200(Suppl 1):167-173.
• [49] TROEGER C,KHALIL AI,RAO CP,et al.Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years[J].JAMA Pediatrics,2018,172(10):958-965.
• [50] KAWAI K,O'BRIEN MA,GOVEIA MG,et al.Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia:a systematic review[J].Vaccine,2012,30(7):1244-1254.
• [51] WANG JX,ZHOU HL,MO ZJ,et al.Burden of viral gastroenteritis in children living in rural China:population-based surveillance[J].International Journal of Infectious Diseases,2020,90:151-160.
• [52] ZHANG J,DUAN ZJ,PAYNE DC,et al.Rotavirus-specific and overall diarrhea mortality in Chinese children younger than 5 years:2003 to 2012[J].The Pediatric Infectious Disease Journal,2015,34(10):233-237.
• [53] JIN H,WANG B,FANG Z,et al.Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China[J].Vaccine,2011,29(44):7801-7806.
• [54] CHANDRAN A,HEINZEN RR,SANTOSHAM M,et al.Nosocomial rotavirus infections:a systematic review[J].The Journal of Pediatrics,2006,149(4):441-447.
• [55] BURKE RM,TATE JE,KIRKWOOD CD,et al.Current and new rotavirus vaccines[J].Current Opinion in Infectious Diseases,2019,32(5):435-444.
• [56] KARLA SW,HANNA B,NICHOLAS H,et al.Vaccines for preventing rotavirus diarrhoea:vaccines in use[J].The Cochrane Database of Systematic Reviews,2019,2019(10):CD008521.
• [57] BURNETT E,PARASHAR UD,TATE JE.Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old:2006-2019[J].The Journal of Infectious Diseases,2020,222(10):1731-1739.
• [58] XIA S,DU J,SU J,et al.Efficacy,immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine(LLR3) in healthy Chinese infants:a randomized,double-blind,placebo-controlled trial[J].Vaccine,2020,38(46):7393-7400.
• [59] 国家药品监督管理局.口服五价重配轮状病毒减毒活疫苗(Vero细胞)中国大陆说明书[S].2019-08-09.
• [60] VESIKARI T,MATSON DO,DENNEHY P,et al.Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine[J].The New England Journal of Medicine,2006,354(1):23-33.
• [61] MO Z,MO Y,LI M,et al.Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants:a randomized,double-blind,placebo-controlled trial[J].Vaccine,2017,35(43):5897-5904.
• [62] BOOM JA,TATE JE,SAHNI LC,et al.Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States[J].Pediatrics,2010,125(2):199-207.
• [63] BAKER JM,DAHL RM,CUBILO J,et al.Effects of the rotavirus vaccine program across age groups in the United States:analysis of national claims data,2001-2016[J].BMC Infectious Diseases,2019,19(1):186.
• [64] MARIA HH,JUKKA M,LEENA H,et al.Decrease of rotavirus gastroenteritis to a low level without resurgence for five years after universal RotaTeq vaccination in Finland[J].The Pediatric Infectious Disease Journal,2016,35(12):1304-1308.
• [65] GAGNEUR A,NOWAK E,LEMAITRE T,et al.Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea:the IVANHOE study[J].Vaccine,2011,29(21):3753-3759.
• [66] PAULKE-KORINEK M,KOLLARITSCH H,ABERLE SW,et al.Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria[J].Vaccine,2013,31(24):2686-2691.
• [67] IWATA S,NAKATA S,UKAE S,et al.Efficacy and safety of pentavalent rotavirus vaccine in Japan:a randomized,double-blind,placebo-controlled,multicenter trial[J].Human Vaccines & Immunotherapeutics,2013,9(8):1626-1633.
• [68] SANTOS VS,MARQUES DP,MARTINS-FILHO PRS,et al.Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America:systematic review and meta-analysis[J].Infectious Diseases of Poverty,2016,5(1):83.
• [69] Advisory Committee Statement (ACS),National Advisory Committee on Immunization (NACI).Updated statement on the use of rotavirus vaccines[J].Canada Communicable Disease Report,2010,36(ACS-4):1-37.
• [70] YEN C,SHIH SM,TATE JE,et al.Intussusception-related hospitalizations among infants before and after private market licensure of rotavirus vaccines in Taiwan,2001-2013[J].The Pediatric Infectious Disease Journal,2017,36(10):252-257.
• [71] KOCH J,HARDER T,KRIES R,et al.Risk of intussusception after rotavirus vaccination[J].Dtsch Arztebl Int,2017,114(15):255-262.
• [72] World Health Organization.Global Advisory Committee on Vaccine Safety,11-12 December 2013[J].Wkeely Epidemiological Record,2014,89(7):53-60.
• [73] World Health Organization.Global Advisory Committee on Vaccine Safety,December 2011[J].Weekly Epidemiological Record,2012,87(6):53-59.
• [74] PAYNE DC,SELVARANGAN R,AZIMI PH,et al.Long-term consistency in rotavirus vaccine protection:RV5 and RV1 vaccine effectiveness in US Children,2012-2013[J].Clinical Infectious Diseases,2015,61(12):1792-1799.
• [75] 国家药品监督管理局.口服轮状病毒活疫苗说明书[S].2020-04-22.
• [76] 刘东磊,杨洁,李安,等.轮状病毒疫苗免疫效果及人体反应观察[J].中国计划免疫,2002,8(3):138-140.
• [77] FU C,WANG M,LIANG J,et al.Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization:a matched case-control study[J].Vaccine,2007,25(52):8756-8761.
• [78] ZHEN SS,LI Y,WANG SM,et al.Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design[J].Emerging Microbes & Infections,2015,4(1):1-6.
• [79] LI J,ZHANG Y,YANG Y,et al.Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age[J].Vaccine,2019,37(27):3611-3616.
• [80] FU C,TATE JE,JIANG B.Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis:further analysis and update[J].Human Vaccines,2010,6(11):953.
• [81] 谢澎,李青,庞兴,等.口服轮状病毒活疫苗罗特威研究进展[J].中国新药杂志,2012,21(10):1107-1109+1174.
• [82] 武文娣,刘大卫,李克莉,等.中国2010年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫,2012,18(5):385-397.
• [83] 武文娣,李克莉,郑景山,等.中国2011年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫,2013,19(2):97-109.
• [84] 武文娣,刘大卫,李克莉,等.中国2012年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫,2014,20(1):1-12+66.
• [85] 叶家楷,李克莉,许涤沙,等.中国2013年疑似预防接种异常反应信息管理系统数据分析[J].中国疫苗和免疫,2015,21(2):121-131+200.
• [86] 叶家楷,李克莉,许涤沙,等.中国2014年疑似预防接种异常反应信息管理系统监测数据分析[J].中国疫苗和免疫,2016,22(2):125-137.
• [87] 叶家楷,李克莉,许涤沙,等.中国2015年疑似预防接种异常反应监测分析[J].中国疫苗和免疫,2017,23(5):481-492+511.
• [88] 许涤沙,李克莉,武文娣,等.中国2016年疑似预防接种异常反应监测数据分析[J].中国疫苗和免疫,2018,24(3):299-309.
• [89] 李克莉,张丽娜,叶家楷,等.中国2017年疑似预防接种异常反应监测[J].中国疫苗和免疫,2020,26(1):9-18.
• [90] World Health Organization.Meeting of the immunization Strategic Advisory Group of Experts,April 2009--conclusions and recommendations[J] Weekly Epidemiological Record,2009,84(23):220-236.
• [91] World Health Organization.Vaccine in National Immunization Programme update[EB/OL].(2020-06-03)[2020-08-24].http://www.who.int/immunization/monitoring_surveillance/VaccineIntroStatus.pptx?ua=1.
• [92] Centers for Disease Control and Prevention.Recommended child and adolescent immunization schedule for ages 18 years or younger,United States,2020[EB/OL].(2020-01-29) [2020-08-24].https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf.
• [93] European Centre for Disease Prevention and Control.ECDC Expert opinion on rotavirus vaccination in infancy[Z].Stockholm:ECDC,2017.
• [94] Anon.Immunization schedule for Thai children recommended by the Pediatric Infectious Disease Society of Thailand 2017[EB/OL].(2017-07-30) [2020-08-24].https://www.pidst.or.th/A573.html.
• [95] HWA CE,EUN PS,YAE-JEAN K,et al.Recommended immunization schedule for children and adolescents:Committee on Infectious Diseases of the Korean Pediatric Society,2018[J].Korean Journal of Pediatrics,2019,62(7):252-256.
• [96] MO Z,MA X,LUO P,et al.Immunogenicity of pentavalent rotavirus vaccine in Chinese infants[J].Vaccine,2019,37(13):1836-1843.
• [97] CIARLET M,SANI-GROSSO R,YUAN G,et al.Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine[J].The Pediatric Infectious Disease Journal,2008,27(10):874-880.
• [98] RODRIGUEZ ZM,GOVEIA MG,STEK JE,et al.Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States[J].The Pediatric Infectious Disease Journal,2007,26(3):221-227.
• [99] KROGER AT,DUCHIN J,VáZQUEZ M.General best practice guidelines for immunization.Best practices guidance of the Advisory Committee on Immunization Practices (ACIP)[EB/OL].(2017-04-20) [2020-08-10].https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html.
• [100] PRIYA P,BERND B,LEENTJE M.Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines[J].Human Vaccines & Immunotherapeutics,2020,DOI:10.1080/21645515.2020.1739485.
• [101] MARTINóN-TORRES F,BOISNARD F,THOMAS S,et al.Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib)[J].Vaccine,2017,35(30):3764-3772.
• [102] 唐伟,甘霖,黄毅,等.口服轮状病毒减毒活疫苗与麻疹-风疹联合减毒活疫苗联合接种的免疫原性和安全性研究[J].川北医学院学报,2016,31(5):710-712+765.
• [103] 黄顺和,唐伟,王娟,等.口服轮状病毒减毒活疫苗与麻疹-风疹-流行性腮腺炎联合减毒活疫苗联合接种的免疫原性和安全性研究[J].预防医学情报杂志,2016,32(5):472-475.
• [104] GOVEIA MG,SUPRUN L,ITZLER RF,et al.Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses[J].The Pediatric Infectious Disease Journal,2010,29(3):263-265.
• [105] GOVEIA MG,RODRIGUEZ ZM,DALLAS MJ,et al.Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants[J].The Pediatric Infectious Disease Journal,2007,26(12):1099-1104.
• [106] 季钗.特殊健康状态儿童预防接种专家共识之一——早产儿与预防接种[J].中国实用儿科杂志,2018,33(10):737-738.
• [107] World Health Organization.Training modules for health care workers.Module 4 - rotavirus vaccine administration[EB/OL].(2018-11-29) [2020-08-24].https://www.who.int/immunization/diseases/rotavirus/training_modules_HC_workers_no_age_restrictions_rotateq/en/.
• [108] MARSHALL GS.The vaccine handbook:a practical guide for clinicians[M]//周祖木,译.疫苗手册:临床医生实用指南(第4版)[M].北京:北京大学医学出版社,2014:1-3.
• [109] 耿启彬,赖圣杰,余建兴,等.中国26省(直辖市、自治区)2011—2014年5岁以下儿童腹泻病例轮状病毒流行特征分析[J].疾病监测,2016,31(6):463-470.
• [110] BURNETT E,JONESTELLER CL,TATE JE,et al.Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea[J].The Journal of Infectious Diseases,2017,215(11):1666-1672.
• [111] PETER G,MYERS MG.Intussusception,rotavirus,and oral vaccines:summary of a workshop[J].Pediatrics,2002,110(6):67.
• [112] BURNETT E,TATE JE,KIRKWOOD CD,et al.Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia[J].Expert Review of Vaccines,2018,17(5):453-460.